Literature DB >> 17929117

Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors.

Yukinori Matsuo1, Yasushi Nagata, Takashi Mizowaki, Kenji Takayama, Takashi Sakamoto, Masato Sakamoto, Yoshiki Norihisa, Masahiro Hiraoka.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the characteristics of mass-like consolidation of the lung on computed tomography (CT) after stereotactic body radiation therapy (SBRT) retrospectively.
METHODS: Forty lung tumors in 37 patients who underwent SBRT were evaluated. Mass-like consolidation was defined as a dense consolidation that newly appeared over or around the original tumor, which included radiation-induced lung injury (RILI) and local recurrence. Time of appearance, initial CT findings (ectatic bronchi and conformity to dose distribution) and serial changes in the size of the mass-like consolidation were evaluated.
RESULTS: Mass-like consolidation appeared in 27 (68%) of 40 tumors at a median of 5 months after SBRT. Follow-up examination revealed that 24 (89%) of the 27 mass-like consolidations were RILI and 3 (11%) were local recurrence. There were no significant differences in the initial CT findings between RILI and local recurrence. The size of the mass-like consolidation varied in the 12 months after SBRT. After 12 months or more, however, the size did not increase in any of the RILI cases, but it did increase in all recurrence cases.
CONCLUSION: Mass-like consolidations were observed in 68% of cases at a median of 5 months after SBRT. Although most of the mass-like consolidations were RILI, local recurrence was observed in a few cases. Early detection of local recurrence after SBRT was difficult.

Entities:  

Mesh:

Year:  2007        PMID: 17929117     DOI: 10.1007/s10147-007-0691-9

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  17 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy.

Authors:  Louis Potters; Michael Steinberg; Christopher Rose; Robert Timmerman; Samuel Ryu; James M Hevezi; James Welsh; Minesh Mehta; David A Larson; Nora A Janjan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-15       Impact factor: 7.038

3.  Treatment planning of stereotactic radiotherapy for solitary lung tumor.

Authors:  Kenji Takayama; Yasushi Nagata; Yoshiharu Negoro; Takashi Mizowaki; Takashi Sakamoto; Masato Sakamoto; Tetsuya Aoki; Shinsuke Yano; Sachiko Koga; Masahiro Hiraoka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-04-01       Impact factor: 7.038

Review 4.  The linear-quadratic formula and progress in fractionated radiotherapy.

Authors:  J F Fowler
Journal:  Br J Radiol       Date:  1989-08       Impact factor: 3.039

5.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.

Authors:  Yasushi Nagata; Kenji Takayama; Yukinori Matsuo; Yoshiki Norihisa; Takashi Mizowaki; Takashi Sakamoto; Masato Sakamoto; Michihide Mitsumori; Keiko Shibuya; Norio Araki; Shinsuke Yano; Masahiro Hiraoka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-19       Impact factor: 7.038

6.  Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.

Authors:  Joern Wulf; Ulrich Haedinger; Ulrich Oppitz; Wibke Thiele; Gerd Mueller; Michael Flentje
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-09-01       Impact factor: 7.038

7.  Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: serial changes on CT.

Authors:  Toshiaki Takeda; Atsuya Takeda; Etsuo Kunieda; Akitoshi Ishizaka; Kazuhiko Takemasa; Kyoko Shimada; Seika Yamamoto; Naoyuki Shigematsu; Osamu Kawaguchi; Jun-Ichi Fukada; Toshio Ohashi; Sachio Kuribayashi; Atsushi Kubo
Journal:  AJR Am J Roentgenol       Date:  2004-05       Impact factor: 3.959

8.  Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.

Authors:  Robert Timmerman; Lech Papiez; Ronald McGarry; Laura Likes; Colleen DesRosiers; Stephanie Frost; Mark Williams
Journal:  Chest       Date:  2003-11       Impact factor: 9.410

9.  Differentiation of radiation-induced fibrosis from recurrent pulmonary neoplasm by CT.

Authors:  P Bourgouin; G Cousineau; P Lemire; P Delvecchio; G Hébert
Journal:  Can Assoc Radiol J       Date:  1987-03       Impact factor: 2.248

10.  Regional dose response to pulmonary irradiation using a manual method.

Authors:  B Levinson; L B Marks; M T Munley; J Poulson; D Hollis; R Jaszczak; R E Coleman
Journal:  Radiother Oncol       Date:  1998-07       Impact factor: 6.280

View more
  21 in total

Review 1.  New techniques for assessing response after hypofractionated radiotherapy for lung cancer.

Authors:  Sarah A Mattonen; Kitty Huang; Aaron D Ward; Suresh Senan; David A Palma
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC.

Authors:  S Arcangeli; L Agolli; L Portalone; M R Migliorino; M G Lopergolo; A Monaco; J Dognini; M C Pressello; S Bracci; V Donato
Journal:  Br J Radiol       Date:  2015-02-03       Impact factor: 3.039

Review 3.  Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?

Authors:  Sarah A Mattonen; Aaron D Ward; David A Palma
Journal:  Br J Radiol       Date:  2016-06-20       Impact factor: 3.039

4.  Early PET-CT After Stereotactic Radiotherapy for Stage 1 Non-small Cell Lung Carcinoma Is Predictive of Local Control.

Authors:  Marguerite Tyran; Nathalie Charrier; Julien Darreon; Anne Madroszyk; Agnes Tallet; Naji Salem
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

5.  Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours.

Authors:  Stefano Arcangeli; Lorenzo Falcinelli; Stefano Bracci; Alessandro Greco; Alessia Monaco; Jessica Dognini; Cinzia Chiostrini; Rita Bellavita; Cynthia Aristei; Vittorio Donato
Journal:  Br J Radiol       Date:  2017-03       Impact factor: 3.039

6.  Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy.

Authors:  Darragh Halpenny; Carole A Ridge; Sara Hayes; Junting Zheng; Chaya S Moskowitz; Andreas Rimner; Michelle S Ginsberg
Journal:  Clin Imaging       Date:  2014-12-12       Impact factor: 1.605

7.  Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysis.

Authors:  Tae-Hyung Kim; Sungmin Woo; Darragh F Halpenny; Yeon Joo Kim; Soon Ho Yoon; Chong Hyun Suh
Journal:  Eur J Radiol       Date:  2020-04-07       Impact factor: 3.528

8.  A Case of Radiation Fibrosis Appearing as Mass-Like Consolidation after SBRT with Elevation of Serum CEA.

Authors:  Kotaro Terashima; Yoshiyuki Shioyama; Satoshi Nomoto; Saiji Ohga; Takeshi Nonoshita; Kayoko Ohnishi; Kazushige Atsumi; Hidetake Yabuuchi; Hideki Hirata; Hiroshi Honda
Journal:  Case Rep Med       Date:  2010-06-06

9.  Illustrative cases of false positive biopsies after stereotactic body radiation therapy for lung cancer based on abnormal FDG-PET-CT imaging.

Authors:  Mamta Singhvi; Percy Lee
Journal:  BMJ Case Rep       Date:  2013-01-22

Review 10.  Surveillance imaging following definitive radiotherapy for non-small cell lung cancer: What is the clinical impact?

Authors:  Brandon A Dyer; Megan E Daly
Journal:  Semin Oncol       Date:  2018-02-09       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.